121424-36-0

Basic information

• Product Name: (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid
• Synonyms: (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid
• CAS NO: 121424-36-0
• Molecular Formula: C₈H₁₂O₂
• Molecular Weight: 140.17968
• Mol File: 121424-36-0.mol

Chemical Properties

• Melting Point: 92-94 °C
• Boiling Point: 251.4±19.0 °C(Predicted)
• Appearance: /
• Density: 1.078±0.06 g/cm3(Predicted)
• PKA: 4.68±0.40(Predicted)
• CAS DataBase Reference: (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid(121424-36-0)
• EPA Substance Registry System: (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid(121424-36-0)

Safety Data

• Hazardous Substances Data: 121424-36-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid is used as a building block for the synthesis of various pharmaceuticals and biologically active compounds due to its unique structure and properties.
Used in Organic Synthesis:
(+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid is used as a key intermediate in the synthesis of complex organic molecules, contributing to the development of new drugs and materials.

Upstream product

• 155156-86-8 (1R)-4-methyl-3-cyclohexene-1-carboxaldehyde 
• 90719-41-8 (4S)-3-((4'S)-1'-methylcyclohexene-4'-carbonyl)-4-(phenylmethyl)-2-oxazolidinone 
• 1562400-53-6 C₁₃H₁₇NO₄ 
• 1384122-49-9 (R)-((S)-4,4-dimethyl-2-oxotetrahydrofuran-3-yl) 4-methylcyclohex-3-ene carboxylate 
• 90719-40-7 (4S,1'R)-3-[(4'-methylcyclohex-3'-ene-1'-yl)carbonyl]-4-iso-propyloxazolidin-2-one 
• 737762-29-7 (+/-)-benzyl 4-(3-hydroxy-4,4-dimethyl-2-oxopyrrolidin-1-yl)benzoate 
• 777087-93-1 (1S,3'R)-[1-(4-benzyloxycarbonylphenyl)-4,4-dimethyl-2-oxopyrrolidin-3-yl] 4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate 
• 777087-95-3 (R)-benzyl 4-(3-hydroxy-4,4-dimethyl-2-oxopyrrolidin-1-yl)benzoate 
• 777087-96-4 (R)-4-(3-hydroxy-4,4-dimethyl-2-oxopyrrolidin-1-yl) benzoic acid 
• 78-79-5 isoprene 
• 6493-79-4 methyl 4-methyl-3-cyclohexene-1-carboxylate 
• 465500-08-7 (1R)-2-endo-[(1R)-4-methylcyclohex-3-en-1-ylcarbonyl]-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol 
• 575343-70-3 (R)-4-Methyl-cyclohex-3-enecarboxylic acid (1R,5R,6R)-6-(2,2-dimethyl-propionylamino)-spiro[4.4]non-1-yl ester 
• 289665-74-3 Acrylic acid (1R,5S,6S)-6-(2,2-dimethyl-propionylamino)-spiro[4.4]non-1-yl ester 

Downstream Products

• 1314795-37-3 (1R)-4-methylcyclohex-3-enecarboxylic acid chloride 
• 1384122-54-6 5-(3,3-dimethyl-but-1-ynyl)-3-[(1,4-dioxa-spiro[4.5]dec-8-yl)-((1R)-4-methyl-cyclohex-3-ene carbonyl)-amino]thiophene-2-carboxylic acid methyl ester 
• 1384122-57-9 5-(3,3-dimethyl-but-1-ynyl)-3-[((1R)-4-methyl-cyclohex-3-enecarbonyl)-(4-oxo-cyclohexyl)-amino]-thiophene-2-carboxylic acid methyl ester 
• 1562406-67-0 (R)-N-(5-(3,3-dimethylbut-1-yn-1-yl)thiophen-3-yl)-4-methyl-N-(4-oxocyclohexyl)cyclohex-3-enecarboxamide 
• 1562406-69-2 (R)-N-(5-(3,3-dimethylbut-1-yn-1-yl)thiophen-3-yl)-4-methyl-N-((3S,6S)-1-oxaspiro[2.5]octan-6-yl)cyclohex-3-enecarboxamide 
• 1485471-12-2 5-(3,3-dimethylbut-1-yn-1-yl)-3-((R)-4-methyl-N-((3S,6S)-1-oxaspiro[2.5]octan-6-yl)cyclohex-3-enecarboxamido)thiophene-2-carboxylic acid 
• 1403859-14-2 2-(tert-butylamino)-4-{[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino}pyrimidine-5-carboxamide 
• 1403864-94-7 tert-butyl ((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)carbamate 
• 1403864-98-1 (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride 
• 141484-10-8 (-)-(1R)-N,4-dimethyl-3-cyclohexenamine 
• 141484-12-0 (+)-(1R)-N,4-dimethyl-N-(4-methyl-3-cyclohexenyl)-3-pentenamide 
• 141484-13-1 (+)-(1R)-N,4-dimethyl-N-(4-methyl-3-pentenyl)-3-cyclohexenamine 
• 1403864-55-0 tert-butyl 3-hydroxy-4-methylcyclohexylcarbamate 

Relevant articles and documents

Silent catalytic promiscuity in the high-fidelity terpene cyclase δ-cadinene synthase

δ-Cadinene synthase (DCS) is a high-fidelity sesquiterpene synthase that generates δ-cadinene as the sole detectable organic product from its natural substrate (E,E)-FDP. Previous work with this enzyme using substrate analogues revealed the ability of DCS

Synthesis of a Chiral Auxiliary Family from Levoglucosenone and Evaluation in the Diels-Alder Reaction

A new family of chiral auxiliaries has been developed based on the lignocellulosic biomass pyrolysis product levoglucosenone. A promising single stereoisomer with an alcohol and π-stacking phenyl substituents was prepared in excellent yield in two steps from dihydrolevoglucosenone without chromatography on >50 g scale. Acrylate esters prepared from the auxiliaries underwent diastereoselective Lewis acid promoted Diels-Alder reactions with cyclopentadiene (endo / exo 98:2, endo d. r. up to 98:2), dimethylbutadiene (d.r. 93:7), and isoprene (d.r. > 98:2).

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

Provided herein are formulations, processes, solid forms and methods of use relating to 2- (tert-butylamino)-4-((lR,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5- carboxamide.

SYNTHESIS OF AN ANTIVIRAL COMPOUND

The present disclosure provides processes for the preparation of a compound of Formula I: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates to compounds of formula.

SYNTHESIS OF AN ANTIVIRAL COMPOUND

The present disclosure provides a processes for the preparation of a compound of Formula I: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates to compounds of Formula I.

METHODS FOR TREATING HCV

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

METHODS FOR TREATING HCV

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

THIOPHEN-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS INHIBITORS OF FLAVIVIRIDAE VIRUSES

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections (e.g. hepatitis C infections), particularly drug

Second generation levoglucosenone-derived chiral auxiliaries. Scope and application in asymmetric Diels-Alder reactions

Chiral alcohols were designed and easily prepared from levoglucosenone, a biomass-derived valuable synthon. These alcohols were tested as chiral auxiliaries in asymmetric Diels-Alder reactions between the corresponding acrylates with acyclic and cyclic di